Examkin

Question

Difficulty: MediumImmunologic and Inflammatory Processes

A 38-year-old man is evaluated in the hospital for a progressive rash and severe diarrhea. Five weeks ago, he underwent a matched-unrelated donor allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia. His conditioning regimen included total body irradiation and high-dose cyclophosphamide. Over the past four days, he has developed a diffuse, pruritic maculopapular rash that prominently involves his palms, soles, and posterior trunk. He also reports crampy abdominal pain and large-volume, watery diarrhea, with nursing staff measuring approximately 1.5 liters of stool output yesterday. Vital signs are temperature 38.1°C (100.6°F), blood pressure 110/70 mmHg, heart rate 98/min, and respiratory rate 16/min. Physical examination confirms the described rash and reveals mild scleral icterus. Laboratory studies show:

Total bilirubin: 4.8 mg/dL
Direct bilirubin: 3.5 mg/dL
Alkaline phosphatase: 420 U/L
Aspartate aminotransferase (AST): 85 U/L
Alanine aminotransferase (ALT): 92 U/L

Which of the following best describes the primary immunopathogenesis of this patient's current clinical syndrome?

  1. Activation of mature donor T lymphocytes by recipient histocompatibility antigensAnswer
  2. B
    Recipient CD8+ T lymphocytes mounting a cytotoxic response against donor human leukocyte antigens
  3. C
    Preformed host circulating IgG and IgM antibodies binding to donor vascular endothelium
  4. D
    Reactivation of cytomegalovirus triggering massive cytokine release from host macrophages
  5. E
    Proliferation of donor-derived B lymphocytes driven by unchecked Epstein-Barr virus infection

Answer

Activation of mature donor T lymphocytes by recipient histocompatibility antigens
The correct answer accurately describes the pathophysiology of acute graft-versus-host disease (aGVHD). This patient's presentation 5 weeks after an allogeneic hematopoietic stem cell transplant with a maculopapular rash (classically involving palms and soles), large-volume watery diarrhea, and cholestatic jaundice represents the classic clinical triad of aGVHD. The immunopathogenesis of aGVHD fundamentally requires three conditions: (1) the graft must contain immunocompetent cells (mature donor T lymphocytes), (2) the recipient must express antigens (major or minor histocompatibility antigens) that are not present in the donor, and (3) the recipient must be immunologically compromised (due to the conditioning regimen) and thus unable to destroy the grafted cells. The mature donor T cells recognize host tissues as foreign, proliferate, and mediate widespread tissue damage, primarily targeting the skin, liver, and gastrointestinal epithelium.

Step-by-Step Solution

1
Analyze the patient's history and timeline of symptom onset.
The patient is 5 weeks post-allogeneic hematopoietic stem cell transplantation (HSCT).
The timing is critical for differentiating early post-transplant complications, placing him in the typical window for acute rather than chronic conditions.
2
Identify the clinical syndrome based on the triad of presenting signs.
The combination of a maculopapular rash (including palms and soles), profuse watery diarrhea, and cholestatic liver injury (elevated bilirubin and alkaline phosphatase) is the classic triad of acute graft-versus-host disease (aGVHD).
Recognizing this specific pattern of target organ involvement (skin, gastrointestinal tract, and liver) is essential for diagnosing aGVHD in post-HSCT patients.
3
Determine the precise immunologic mechanism underlying this diagnosis.
In aGVHD, the transplanted (donor) immune system recognizes the recipient (host) tissues as foreign and mounts an immune attack.
Because the host's native immune system was ablated during the conditioning regimen, the host cannot attack the graft. Instead, immunocompetent donor T cells present in the stem cell graft become activated against host major and minor histocompatibility antigens.

Key Concept

The immunopathogenesis of acute graft-versus-host disease (aGVHD) involves donor-derived immunocompetent T cells recognizing and attacking recipient alloantigens, typically manifesting with skin, liver, and gastrointestinal involvement.
Rate this question

Topics

Immunologic and Inflammatory Processes

More questions from this topic